chip-processor

Professional equity research,
state-of-the-art delivery

Benefit from our open access MiFID II compliant research platform, daily newsletters and access to companies at roundtables and conferences.

ResearchHub: your platform for professional research and more

Our MiFID II compliant platform, ResearchHub, is freely accessible and provides analysis and background information on the more than 100 companies we cover. In addition, ResearchHub offers many other features such as event registration, one-on-one meetings with companies, screening of our universe by various criteria, roundtable videos and much more. Have fun exploring!

700++
670+671+672+673+674+675+676+677+678+679+680+681+682+683+684+685+686+687+688+689+690+691+692+693+694+695+696+697+698+699+700+

Updates p. a.

100++
80+81+82+83+84+85+86+87+88+89+90+91+92+93+94+95+96+97+98+99+100+

Events p. a.

100++
95+96+97+98+99+100+

Companies

Newsletter for every need

If you don’t want to miss any of our 700+ updates a year, you can subscribe to our weekday newsletter. Alternatively, there is the Week in Review, which summarises the week’s events on Sundays. And for those investors who prefer direct contact with companies, there is the option of receiving invitations to all events by email.

Recent Research Updates

buy
Bechtle AG: Q4/FY results as pre-announced. Muted outlook for 2025; mwb research confirms to BUY
17. March 2025, 12:21 Read full update
buy
Dermapharm Holding SE: Prelims confirm strong FY performance. Cautious outlook; mwb research upgrades to BUY
17. March 2025, 12:14 Read full update
buy
Viromed Medical AG: Promising study results for PulmoPlas, PT up; mwb research recommends spec. BUY
17. March 2025, 11:28 Read full update